Assignee
APRILBIO CO LTD
KR·3 granted patents·6 pending applications·5 citations·filing 2016–2024
Top patents by PatentIndex Score
9 records- 0192US11773176B2Multispecific antibodies, compositions comprising the same, and vectors and uses thereofAPRILBIO CO LTD·Filed 2023·Granted Oct 3, 2023·1 cites·19 claims
- 0275US2025122254A1Recombinant Fusion Proteins Comprising Interleukin- 18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses ThereofAPRILBIO CO LTD·Filed 2024·Application pending·0 cites
- 0372US9879077B2Anti-serum albumin Fab-effector moiety fusion construct, and a method of preparing the constructAPRILBIO CO LTD·Filed 2016·Granted Jan 30, 2018·3 cites·18 claims
- 0469US10618953B2Method of preparing an anti-serum albumin Fab-effector moiety fusion constructAPRILBIO CO LTD·Filed 2017·Granted Apr 14, 2020·1 cites·16 claims
- 0566US2023073034A1Multispecific antibodies, compositions comprising the same, and vectors and uses thereofAPRILBIO CO LTD·Filed 2021·Application pending·0 cites
- 0664US2023357340A1Recombinant Fusion Proteins Comprising Interleukin-18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses ThereofAPRILBIO CO LTD·Filed 2021·Application pending·0 cites
- 0763US2021230285A1Multispecific antibodies, compositions comprising the same, and vectors and uses thereofAPRILBIO CO LTD·Filed 2020·Application pending·0 cites
- 0857US2023140224A1Recombinant proteins comprising feline granulocyte colony-stimulating factor and antigen binding fragment for serum albumin, and uses thereofAPRILBIO CO LTD·Filed 2021·Application pending·0 cites
- 0954US2023174665A1Monoclonal Antibodies and Antigen Binding Fragments Thereof for Suppressing CD73 Immune Checkpoint and Uses ThereofAPRILBIO CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APRILBIO CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →